Cefpodoxime Proxetil Granule, For Suspension
Product Images NDC 64980-402

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cefpodoxime Proxetil (NDC 64980-402). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (50 mg/5 mL (50 mL Bottle))

Package Label-principal Display Panel (50 mg/5 mL (50 mL Bottle))
Label for Cefpodoxime Proxetil for Oral Suspension, USP, 50 mg/5 mL granules for suspension, 50 mL when constituted. The product is distributed by Rising Pharmaceuticals, Inc. and manufactured in India. The label includes dosage instructions, storage conditions, and warnings, with a barcode and NDC 64980-402-50 visible.*
FDA Label Image

Package Label-principal Display Panel (50 mg/5 mL Carton Label)

Package Label-principal Display Panel (50 mg/5 mL Carton Label)
Packaging label for Cefpodoxime Proxetil for Oral Suspension, USP 50 mg/5 mL by Rising Pharma Holdings, Inc. The label indicates a 50 mL suspension when constituted, with directions for use and storage instructions. The label includes the NDC 64980-402-50, barcode, and distribution details, emphasizing this is an Rx only product for oral use as granules for suspension.*
FDA Label Image

Package Label-principal Display Panel (100 mg/5 mL (50 mL Bottle))

Package Label-principal Display Panel (100 mg/5 mL (50 mL Bottle))
Label for Cefpodoxime Proxetil Oral Suspension, USP, 100 mg/5 mL granules for suspension by Rising Pharmaceuticals, Inc. The label indicates a 50 mL volume when constituted, with directions for storage, usage, and mixing instructions. It includes manufacturer details noting the product is made in India.*
FDA Label Image

Package Label-principal Display Panel (100 mg/5 mL Carton Label)

Package Label-principal Display Panel (100 mg/5 mL Carton Label)
Packaging label for Cefpodoxime Proxetil for Oral Suspension, USP, with strength 100 mg/5 mL, in granule form for suspension, oral use. The label is from Rising Pharma Holdings, Inc. The carton indicates a 50 mL volume when constituted, with instructions for reconstitution and storage, and includes barcodes and NDC 64980-403-50.*
FDA Label Image

Chemical Structure (Cefpodoxime Str)

Chemical Structure (Cefpodoxime Str)
Chemical structure diagram of Cefpodoxime Proxetil, showing its molecular components and bonds representing the active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.